SAB Biotherapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
SABS Nasdaq 8731 https://www.sab.bio/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for SAB Biotherapeutics Inc

SAB Biotherapeutics (NASDAQ:SABS) Will Have To Spend Its Cash Wisely - Sep 23rd, 2024 2:53 pm
SAB BIO CEO to Participate in Fireside Chat at 2024 Cantor Global Healthcare Conference - Sep 13th, 2024 11:00 am
SAB BIO Provides SAB-142 Clinical Trial Progress Update at the European Association for the Study of Diabetes Annual Meeting - Sep 9th, 2024 11:00 am
SAB BIO to Present at the European Association for the Study of Diabetes 60th Annual Meeting - Sep 4th, 2024 11:05 am
SAB BIO Announces Second Quarter 2024 Financial Results and Provides Company Updates - Aug 8th, 2024 9:51 pm
SAB BIO Announces Founding of Clinical Advisory Board to Guide the Development of SAB-142 for Type 1 Diabetes - Aug 5th, 2024 11:30 am
SAB BIO Appoints Lucy To as Chief Financial Officer - Jul 31st, 2024 11:30 am
SAb Biotherapeutics Rebrands as SAB BIO - Jun 20th, 2024 11:20 am
SAB Biotherapeutics to Present at the American Diabetes Association 84th Scientific Sessions - Jun 18th, 2024 5:10 pm
SAB Biotherapeutics Announces Departure of Chief Financial Officer - May 30th, 2024 8:45 pm
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics - May 21st, 2024 11:15 am
SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company Updates - May 20th, 2024 9:45 pm
SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors - May 6th, 2024 11:15 am
SAB Biotherapeutics Provides SAB-142 Trial Update - Apr 16th, 2024 11:15 am
SAB Biotherapeutics to Present at INNODIA Annual Meeting - Apr 8th, 2024 11:15 am
SAB Biotherapeutics to Present at the Needham Virtual Healthcare Conference - Apr 4th, 2024 11:15 am
SAB Biotherapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags - Apr 1st, 2024 10:56 am
SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results - Mar 29th, 2024 11:15 am
SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment - Mar 25th, 2024 2:15 pm
SAB Biotherapeutics to Present at the BIO CEO & Investor Conference - Feb 23rd, 2024 1:00 pm